Additionally, it remains to be established how inflammation, a hallmark of cardiovascular disease and a known regulator of hepcidin, impinges on the cardiac hepcidin/ferroportin axis, and on cardiomyocyte iron levels. This evidence concerns the gene HAMP and cardiovascular disorder.